Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04102618
Title A Window-of-opportunity Study of Pelareorep in Early Breast Cancer (AWARE-1)
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Oncolytics Biotech

triple-receptor negative breast cancer

Her2-receptor negative breast cancer

Her2-receptor positive breast cancer


Atezolizumab + Pelareorep

Atezolizumab + Pelareorep + Trastuzumab

Letrozole + Pelareorep

Atezolizumab + Letrozole + Pelareorep

Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona Badalona Spain Details
Hospital Clínic de Barcelona Barcelona Spain Details
Hospital Quirón Dexeus Barcelona Spain Details
Hospital Moisés Broggi Esplugues De Llobregat Spain Details
Hospital Fuenlabrada Madrid Spain Details
Hospital La Paz Madrid Spain Details
Hospital Puerta de Hierro de Majadahonda Madrid Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid Spain Details
Hospital Clínico Universitario Virgen Arrixaca Murcia Spain Details
Hospital Universitario Virgen Macarena Sevilla Spain Details
Hospital Clínico Universitario de Valencia Valencia Spain Details
Instituto Valenciano de Oncología Valencia Spain Details
Hospital Clínico Lozano Blesa Zaragoza Spain Details
*Shaded cells indicate that there was no data available from for the field